Literature DB >> 27620350

Combined papillary muscle sling and ring annuloplasty for moderate-to-severe secondary mitral regurgitation.

Christos G Mihos1,2, Romain Capoulade3, Evin Yucel3, Serguei Melnitchouk4, Judy Hung3.   

Abstract

BACKGROUND: There is a 30-60% incidence of recurrent mitral regurgitation (MR) after mitral valve annuloplasty (Ring) for secondary MR. A concomitant papillary muscle sling (Ring+Sling) may improve valve repair by providing a more physiologic geometry of the mitral apparatus.
METHODS: We retrospectively identified 58 consecutive patients with moderate-to-severe secondary MR who underwent a Ring+Sling repair, between March 2008 and May 2015. A Ring+Sling consisted of combined annuloplasty and papillary muscle approximation, utilizing a 4-mm polytetrafluoroethylene graft placed around the base of each muscle. Comparison of echocardiographic variables with patients who underwent a Ring only was performed utilizing 2:1 propensity-score matching (Ring+Sling = 34; Ring = 17).
RESULTS: The baseline demographics were similar between the groups. The mean time to follow-up echocardiogram was 10.1 months (range 0.25-42 months). At follow-up, a Ring+Sling repair was associated with a lower mitral valve tenting height (p = 0.005), mitral valve tenting area (p = 0.009), and interpapillary muscle distance (p = 0.001); a smaller posterior leaflet tethering angle (p = 0.003); and a greater leaflet coaptation length (p = 0.002), when compared with Ring only. Recurrence of moderate or greater MR occurred significantly less in the Ring+Sling group (14.7%), as compared with Ring only (35.3%) (p < 0.001). Finally, actuarial survival at three years was 87% for Ring+Sling, and 82% for Ring only (p = 0.49).
CONCLUSIONS: A Ring+Sling for secondary MR results in favorable changes in the mitral valve apparatus geometry, and is associated with less MR recurrence in the early postoperative period. Longer-term follow-up is needed to assess its durability and effects on left ventricular remodeling and survival.
© 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27620350     DOI: 10.1111/jocs.12843

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  8 in total

1.  Staged percutaneous coronary intervention followed by minimally invasive mitral valve surgery versus combined coronary artery bypass graft and mitral valve surgery for two-vessel coronary artery disease and moderate to severe ischemic mitral regurgitation.

Authors:  Christos G Mihos; Steve Xydas; Roy F Williams; Andrés M Pineda; Evin Yucel; Hector Davila; Nirat Beohar; Orlando Santana
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

2.  Left ventricle-mitral valve ring size mismatch: understanding the limitations of mitral valve repair for ischemic mitral regurgitation.

Authors:  Christos G Mihos; Evin Yucel; Orlando Santana
Journal:  Ann Transl Med       Date:  2017-01

Review 3.  Functional mitral regurgitation: an overview for surgical management framework.

Authors:  Francesco Nappi; Sanjeet Singh Avatar Singh; Orlando Santana; Christos G Mihos
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

4.  Mitral valve repair and subvalvular intervention for secondary mitral regurgitation: a systematic review and meta-analysis of randomized controlled and propensity matched studies.

Authors:  Christos G Mihos; Steve Xydas; Evin Yucel; Romain Capoulade; Roy F Williams; Maurice Mawad; Guillermo Garcia; Orlando Santana
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

Review 5.  Minimally invasive valve surgery in high-risk patients.

Authors:  Orlando Santana; Steve Xydas; Roy F Williams; S Howard Wittels; Evin Yucel; Christos G Mihos
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

Review 6.  Multimodality imaging assessment of mitral valve anatomy in planning for mitral valve repair in secondary mitral regurgitation.

Authors:  Romain Capoulade; Nicolas Piriou; Jean-Michel Serfaty; Thierry Le Tourneau
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

7.  Aortic valve replacement in patients with a left ventricular ejection fraction ≤35% performed via a minimally invasive right thoracotomy.

Authors:  Orlando Santana; Steve Xydas; Roy F Williams; Angelo La Pietra; Maurice Mawad; Vicente Behrens; Esteban Escolar; Christos G Mihos
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

8.  Pre-surgical Prediction of Ischemic Mitral Regurgitation Recurrence Using In Vivo Mitral Valve Leaflet Strains.

Authors:  Harshita Narang; Bruno V Rego; Amir H Khalighi; Ahmed Aly; Alison M Pouch; Robert C Gorman; Joseph H Gorman Iii; Michael S Sacks
Journal:  Ann Biomed Eng       Date:  2021-04-09       Impact factor: 4.219

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.